Wells Pharmacy Network recalls Testosterone Pellets: Superpotent drug risk
Wells Pharmacy Network recalls specific testosterone pellets due to potential superpotent and subpotent drug risks. Affected lots from 2016-2017 may cause harmful drug levels.
Recall notice
Superpotent and Subpotent drugs
Contact the company
What happened, in plain English
Wells Pharmacy Network recalls testosterone pellets that may contain superpotent or subpotent drug levels. This could lead to harmful effects if used without proper medical supervision. Read more at govinfonow.com/recall/42430-wells-pharmacy-network-recalls-testosterone-pellets-superpotent-drug-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/42430-wells-pharmacy-network-recalls-testosterone-pellets-superpotent-drug-risk · Updated October 9, 2026 · FDA enforcement record: FDA #D-0126-2017
Cite this page
“Wells Pharmacy Network recalls Testosterone Pellets: Superpotent drug risk.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42430-wells-pharmacy-network-recalls-testosterone-pellets-superpotent-drug-risk. Based on FDA recall #D-0126-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0126-2017%22&limit=1).
Why it’s dangerous
The pellets may contain drug levels that are too high (superpotent) or too low (subpotent) compared to intended medical use. This could cause harmful effects such as hormone imbalances or treatment failure.
Who’s affected
People who have received testosterone pellets compounded by Wells Pharmacy Network between October 2016 and January 2017 are affected. Those with medical conditions requiring precise hormone levels are at higher risk.
How to tell if you have this one
Check for lot numbers 04072016@4, 06162016@2, or CA07112016@4 on the packaging. The product was sold between October 2016 and January 2017 with specific expiration dates.
- Brand
Wells Pharmacy Network- Category
Drug
All 7 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Status
Terminated- Distribution
U.S.
| Recall number | Product, codes & lots | Quantity | Class |
|---|---|---|---|
| D-0126-2017 | Testosterone 200 mg/Anastrozole 9 mg Pellet, Compounded by: Wells Pharmacy Network; BUD: 10/04/2016, Lot number 04072016@40 BUD: 12/03/2016, Lot number 06162016@2 BUD: 01/07/2017, Lot number CA07112016@4 | 690 pellets | Class II |
| D-0127-2017 | Testosterone Cholesterol ,100 mg Pellet, Compounded by: Wells Pharmacy Network; Lot Number 06072016@5, BUD 12/04/2016 | 1 pellet | Class III |
| D-0128-2017 | Testosterone 60 mg/Anastrazole 4 mg Pellet, Compounded by: Wells Pharmacy Network; Lot Number 08012016@2, BUD 01/28/2017 | 358 pellets | Class II |
| D-0129-2017 | Testosterone 12.5 mg Pellet, Compounded by: Wells Pharmacy Network; Lot Number 08052016@3, BUD 02/01/2017 | 322 pellets | Class III |
| D-0130-2017 | Estradiol 3 mg Pellet, Compounded by: Wells Pharmacy Network; Lot Number 08082016@1, BUD: 02/04/2017 | 301 pellets | Class III |
| D-0131-2017 | Testosterone 200 mg/Anastrazole 20mg Pellet, Compounded by: Wells Pharmacy Network; Lot Number 08162016@5, BUD: 02/12/2017 | 318 pellets | Class II |
| D-0132-2017 | Estradiol 12.5 mg Pellet, Compounded by: Wells Pharmacy Network; Lot Number 08172016@9, BUD: 02/13/2017 | 353 pellets | Class III |
What to do — step by step
Check Product Details
Look for lot numbers 04072016@4, 06162016@2, or CA07112016@4 on the packaging.
How this recall unfolded
Recall timeline
FDA terminated this recall 6 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0126-2017 (September 19, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0126-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.